01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

#POLB Poolbeg Pharma PLC – POLB 001 Patent Granted in Korea March 20, 2025 – Posted in: Poolbeg Pharma (POLB)

20 March 2025 – Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs, announces that the Korean Intellectual Property Office has notified the Company of its official decision to grant Poolbeg’s Republic of Korea Immunomodulator II patent application providing protection to POLB 001 for the treatment of severe influenza to December 2038.   POLB 001 is a potent and selective p38 MAP…

Continue reading

#VELA investee co. #ENSI EnSilica PLC – Announcement by SIAE Microelettronica re. Contract September 27, 2024 – Posted in: Vela Technologies Plc (VELA)

EnSilica, a leading chip madker of mixed signal ASICs (Application Specific Integrated Circuits), notes the following press announcement released today by SIAE Microelettronica regarding the contract announced by EnSilica on 2 September 2024: “SIAE MICROELETTRONICA, a leading provider of innovative microwave radio and wireless network solutions, has selected EnSilica, a leading turnkey supplier of mixed signal ASICs and SoCs, to assist the design of Application-Specific Integrated Circuits (ASICs) for its next-generation telecommunication infrastructure products.  …

Continue reading

#VELA investee co. #ENSI EnSilica PLC – Result of WRAP Retail Offer & Notice of GM May 30, 2024 – Posted in: Vela Technologies Plc (VELA)

On 24 May 2024 EnSilica (AIM: ENSI), a leading chip maker of mixed signal ASICs (Application Specific Integrated Circuits), announced that it has conditionally raised approximately £4.9 million pursuant to a Placing and Subscription and separately launched the WRAP Retail Offer to existing shareholders of the Company. The WRAP Retail Offer closed at 4.00 p.m. yesterday, 29 May 2024, and the Directors are pleased to announce that it was oversubscribed and demand has therefore been scaled back to…

Continue reading

#POLB Poolbeg Pharma PLC – Significant POLB 001 Patent Granted in USA May 1, 2024 – Posted in: Poolbeg Pharma (POLB)

1 May 2024- Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces that, further to its announcement on 20 March 2024, the Company has received the fully granted patent from the US Patent Office for its Immunomodulator II patent application.   The claims cover a class of drugs (including POLB 001) for treating hypercytokinaemia (cytokine…

Continue reading

#VELA investee co. #ENSI EnSilica PLC – Exercise of Warrants, Issue of Equity & TVR April 4, 2024 – Posted in: Vela Technologies Plc (VELA)

EnSilica, a leading chip maker of mixed signal ASICs (Application Specific Integrated Circuits), announces that it has received notice for the exercise of warrants to subscribe for 40,000 new ordinary shares of 0.1 pence each in the Company (the “Ordinary Shares”).  The exercise price of the warrants is 55 pence per new Ordinary Share and will generate proceeds of £22,000.00 for the Company.   The warrants were issued to subscribers of new Ordinary Shares in…

Continue reading

#COIN Coinsilium – Greengage Investment Update December 6, 2021 – Posted in: Blog, Coinsilium (COIN)

London, UK, 6 December 2021 – Coinsilium Group Limited (AQSE: COIN) (OTCQB: CINGF), the Blockchain and Open Finance venture builder, hereby reports that it has received a shareholder update from portfolio company Greengage Global Holding Ltd (“Greengage”). The Company announced on 8 September 2021 that it had invested GBP200,000 in convertible notes and had also taken GBP300,000 equity in a secondary stake sale that valued Greengage at GBP27.3m. The investment was undertaken via Coinsilium’s wholly-owned Gibraltar registered…

Continue reading